<DOC>
	<DOCNO>NCT02749695</DOCNO>
	<brief_summary>The placental drug Melsmon® effective correction insomnia climacteric symptom premenopausal woman . Decrease MMI show group Melsmon® Placebo , significant patient use Melsmon® .</brief_summary>
	<brief_title>Efficiency Placental Drug Melsmon® Correction Climacteric Symptoms Premenopausal Women</brief_title>
	<detailed_description>There 40 woman observation , mild moderate symptom climacteric syndrome sleep disorder ( investigator evaluate modified Kupperman Index ) . All patient randomize help envelope method allocation ratio 1:1 ( one-to-one ) . 20 woman prescribe placenta extract Melsmon 20 receive placebo 4 month .</detailed_description>
	<criteria>More 40 year age Irregular menstrual cycle Climacteric symptom , include sleep disorder folliculestimulating hormone &gt; 20 milli international units/ml Noncontrolled hypertension ( 140 mm Hg ) Decompensated chronic disease cardiovascular system , myocardial infarction , history stroke Diabetes mellitus Kidney hepatic dysfunction Cancer Breast fibroadenoma , adenomas cyst Uterine fibroid dominant nodule diameter ˃ 2 cm , Endometrial hyperplasia Individual drug idiosyncrasy Intake drug correction climacteric symptom sleep disorder</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>52 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>menopause , climacteric syndrome , insomnia , placental extract</keyword>
</DOC>